QUINAZOLINE-PYRAZOLE DERIVATIVES FOR THE TREATMENT OF CANCER-RELATED DISORDERS

QUINAZOLINE-PYRAZOLE DERIVATIVES FOR THE TREATMENT OF CANCER-RELATED DISORDERS

A compound that is an inhibitor of at least one of the A2A and A2B adenosine receptors having Formula (I)and compositions containing the compound and methods for synthesizing the compound, are described herein. The use of such compound and compositions for the treatment of a diverse array of disease...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LELETI, Manmohan Reddy, POWERS, Jay Patrick, MILES, Dillon Harding, ROSEN, Brandon Reid, SHARIF, Ehesan Ul
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LELETI, Manmohan Reddy
POWERS, Jay Patrick
MILES, Dillon Harding
ROSEN, Brandon Reid
SHARIF, Ehesan Ul
description A compound that is an inhibitor of at least one of the A2A and A2B adenosine receptors having Formula (I)and compositions containing the compound and methods for synthesizing the compound, are described herein. The use of such compound and compositions for the treatment of a diverse array of diseases, disorders, and conditions, including cancer- and immune-related disorders that are mediated, at least in part, by the adenosine A2A receptor and/or the adenosine A2B receptor.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3634417C0</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3634417C0</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3634417C03</originalsourceid><addsrcrecordid>eNrjZPALDPX0c4zy9_H0c9UNiAwCMV0VXFyDPMMcQzzDXIMV3PyDFEI8XBVCglwdQ3xd_UIU_N0UnB39nF2DdINcfRxDXF0UXDyD_YOAmoJ5GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakm8a4CxmbGJiaG5s4ExEUoA_U8uiQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>QUINAZOLINE-PYRAZOLE DERIVATIVES FOR THE TREATMENT OF CANCER-RELATED DISORDERS</title><source>esp@cenet</source><creator>LELETI, Manmohan Reddy ; POWERS, Jay Patrick ; MILES, Dillon Harding ; ROSEN, Brandon Reid ; SHARIF, Ehesan Ul</creator><creatorcontrib>LELETI, Manmohan Reddy ; POWERS, Jay Patrick ; MILES, Dillon Harding ; ROSEN, Brandon Reid ; SHARIF, Ehesan Ul</creatorcontrib><description>A compound that is an inhibitor of at least one of the A2A and A2B adenosine receptors having Formula (I)and compositions containing the compound and methods for synthesizing the compound, are described herein. The use of such compound and compositions for the treatment of a diverse array of diseases, disorders, and conditions, including cancer- and immune-related disorders that are mediated, at least in part, by the adenosine A2A receptor and/or the adenosine A2B receptor.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230712&amp;DB=EPODOC&amp;CC=EP&amp;NR=3634417C0$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230712&amp;DB=EPODOC&amp;CC=EP&amp;NR=3634417C0$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LELETI, Manmohan Reddy</creatorcontrib><creatorcontrib>POWERS, Jay Patrick</creatorcontrib><creatorcontrib>MILES, Dillon Harding</creatorcontrib><creatorcontrib>ROSEN, Brandon Reid</creatorcontrib><creatorcontrib>SHARIF, Ehesan Ul</creatorcontrib><title>QUINAZOLINE-PYRAZOLE DERIVATIVES FOR THE TREATMENT OF CANCER-RELATED DISORDERS</title><description>A compound that is an inhibitor of at least one of the A2A and A2B adenosine receptors having Formula (I)and compositions containing the compound and methods for synthesizing the compound, are described herein. The use of such compound and compositions for the treatment of a diverse array of diseases, disorders, and conditions, including cancer- and immune-related disorders that are mediated, at least in part, by the adenosine A2A receptor and/or the adenosine A2B receptor.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPALDPX0c4zy9_H0c9UNiAwCMV0VXFyDPMMcQzzDXIMV3PyDFEI8XBVCglwdQ3xd_UIU_N0UnB39nF2DdINcfRxDXF0UXDyD_YOAmoJ5GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakm8a4CxmbGJiaG5s4ExEUoA_U8uiQ</recordid><startdate>20230712</startdate><enddate>20230712</enddate><creator>LELETI, Manmohan Reddy</creator><creator>POWERS, Jay Patrick</creator><creator>MILES, Dillon Harding</creator><creator>ROSEN, Brandon Reid</creator><creator>SHARIF, Ehesan Ul</creator><scope>EVB</scope></search><sort><creationdate>20230712</creationdate><title>QUINAZOLINE-PYRAZOLE DERIVATIVES FOR THE TREATMENT OF CANCER-RELATED DISORDERS</title><author>LELETI, Manmohan Reddy ; POWERS, Jay Patrick ; MILES, Dillon Harding ; ROSEN, Brandon Reid ; SHARIF, Ehesan Ul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3634417C03</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>LELETI, Manmohan Reddy</creatorcontrib><creatorcontrib>POWERS, Jay Patrick</creatorcontrib><creatorcontrib>MILES, Dillon Harding</creatorcontrib><creatorcontrib>ROSEN, Brandon Reid</creatorcontrib><creatorcontrib>SHARIF, Ehesan Ul</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LELETI, Manmohan Reddy</au><au>POWERS, Jay Patrick</au><au>MILES, Dillon Harding</au><au>ROSEN, Brandon Reid</au><au>SHARIF, Ehesan Ul</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>QUINAZOLINE-PYRAZOLE DERIVATIVES FOR THE TREATMENT OF CANCER-RELATED DISORDERS</title><date>2023-07-12</date><risdate>2023</risdate><abstract>A compound that is an inhibitor of at least one of the A2A and A2B adenosine receptors having Formula (I)and compositions containing the compound and methods for synthesizing the compound, are described herein. The use of such compound and compositions for the treatment of a diverse array of diseases, disorders, and conditions, including cancer- and immune-related disorders that are mediated, at least in part, by the adenosine A2A receptor and/or the adenosine A2B receptor.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP3634417C0
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title QUINAZOLINE-PYRAZOLE DERIVATIVES FOR THE TREATMENT OF CANCER-RELATED DISORDERS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T01%3A12%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LELETI,%20Manmohan%20Reddy&rft.date=2023-07-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3634417C0%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true